• Innovations in Healthcare: Stryker's FDA Approval, OneMedNet's Funding, and CHMP's Nod to RYBREVANT

  • Aug 1 2024
  • Length: 5 mins
  • Podcast

Innovations in Healthcare: Stryker's FDA Approval, OneMedNet's Funding, and CHMP's Nod to RYBREVANT

Listen for free

View show details

  • Summary

  • Recent Advances in Medical Technologies and Therapies: Stryker's innovative spine surgery technology receives FDA approval, OneMedNet raises $4.6 million in private funding, and the CHMP endorses RYBREVANT® (amivantamab) combined with chemotherapy for advanced EGFR-mutated NSCLC post-therapy failure.
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Innovations in Healthcare: Stryker's FDA Approval, OneMedNet's Funding, and CHMP's Nod to RYBREVANT

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available